Lipitor Demonstrates Improvment in Kidney Function in Patients With Heart Disease
Lipitor is an HMG CoA reductase inhibitor. It blocks the production of cholesterol (a type of fat) in the body.

Manufacturer of Lipitor, Pfizer Inc. announced that it showed improved kidney function in patients with heart disease in a large clinical study.
The drug maker also said improvement in kidney function was significantly greater among patients taking the 80-milligram highest dose of Lipitor.
Filed under Health, Heart Disease, Kidney
You may also like to read
- Frequent Dialysis Does Not Improve Survival Rate In Acute Renal Failure
- Kidney Disease In USA: Reasons And Prevention
- 25% African Americans With Chronic Renal Failure From Blood Pressure Do not Improve With Best Available Treatment
- Over Dose of Anti-Cholesterol Drug Reverses Heart Disease
- Ignorance About Heart Disease Increases Death Risks
































